Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C M Mendel

Showing results (51-60 of 55) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 55 results.
Journal of Human Hypertension|February 13, 2002
Efficacy and safety of sibutramine for weight loss in obese patients with hypertension well controlled by beta-adrenergic blocking agents: a placebo-controlled, double-blind, randomised trialJ J Sramek, M T Leibowitz, S P Weinstein, et al.
Obesity Research|April 2, 1999
Sibutramine produces dose-related weight lossG A Bray, G L Blackburn, J M Ferguson, et al.
BMC Medicine|October 18, 2018
Gender differences in tuberculosis treatment outcomes: a post hoc analysis of the REMoxTB studyM E Murphy, G H Wills, S Murthy, et al.
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|May 29, 2021
Pretomanid with bedaquiline and linezolid for drug-resistant TB: a comparison of prospective cohortsS Oelofse, A Esmail, A H Diacon, et al.
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|March 25, 2021
A partially randomised trial of pretomanid, moxifloxacin and pyrazinamide for pulmonary TBC D Tweed, G H Wills, A M Crook, et al.
Pageof 6

Showing results (51-60 of 55) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 55 results.
Journal of Human Hypertension|February 13, 2002
Efficacy and safety of sibutramine for weight loss in obese patients with hypertension well controlled by beta-adrenergic blocking agents: a placebo-controlled, double-blind, randomised trialJ J Sramek, M T Leibowitz, S P Weinstein, et al.
Obesity Research|April 2, 1999
Sibutramine produces dose-related weight lossG A Bray, G L Blackburn, J M Ferguson, et al.
BMC Medicine|October 18, 2018
Gender differences in tuberculosis treatment outcomes: a post hoc analysis of the REMoxTB studyM E Murphy, G H Wills, S Murthy, et al.
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|May 29, 2021
Pretomanid with bedaquiline and linezolid for drug-resistant TB: a comparison of prospective cohortsS Oelofse, A Esmail, A H Diacon, et al.
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|March 25, 2021
A partially randomised trial of pretomanid, moxifloxacin and pyrazinamide for pulmonary TBC D Tweed, G H Wills, A M Crook, et al.
Pageof 6